I wrote in August that Zogenix was a biotech stock that could soar in September. And it did. Zogenix stock more than doubled on Friday after announcing very good results from a late-stage study of experimental drug ZX008 in treating …
(Reuters) - Zogenix Inc’s experimental treatment for a rare form of epilepsy met the main goal in a late-stage study, the company said on Friday, more than doubling the value of its shares and hurting those of peer GW Pharmaceuticals . In …
Shares of orphan drugmaker Zogenix (NASDAQ: ZGNX) opened almost 150% higher after heavy pre-market trading on Friday. The small-cap biotech got its big lift from a positive top line readout for its experimental Dravet syndrome drug, …
If you want a Stock Review on IMNP, ZGNX, SHPG, or ABBV then come over to http://dailystocktracker.com/register/ …
On Friday, shares of pharmaceutical company Zogenix Inc. ZGNX are skyrocketing, and as of 1:05 PM EST, the stock is trading up over 171% to $34.90 per share. ZGNX closed the day on Thursday at $12.88 per share, meaning the small …
Dec 22 (Reuters) - Zogenix Inc: * ZOGENIX INC - MAY ISSUE AND SELL SHARES OF COMMON STOCK HAVING …
Zogenix (NASDAQ: ZGNX) has entered into a definitive agreement to sell its Zohydro ER (hydrocodone bitartrate) business to Pernix Therapeutics (Nasdaq ... $20 million in common stock and provide a $50 million short-term …
Zogenix (NASDAQ: ZGNX) announced today that it intends to offer and sell $60 million of shares of its common stock in an underwritten public offering. Zogenix also expects to grant to the underwriters for the offering a 30-day option to …